Brief: InspireMD Announces Successful First-In-Human Procedure Utilizing CGuard Prime, Its Next Generation Carotid Artery Stent Platform
01/05/2023 13:18
May 1 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN PROCEDURE
UTILIZING CGUARD PRIME, ITS NEXT GENERATION CAROTID ARTERY STENT
(CAS) PLATFORM
* INSPIREMD INC - CGUARDIANS ENROLLMENT ON TRACK TO BE
COMPLETED
BY END OF Q2 2023
Source text for Eikon: ID:nGNX48xlPG
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand